| Gregory D Hammond, MD | |
|
613 E Fort Union, Suite #a102, Midvale, UT 84047-5531 | |
| (801) 294-9333 | |
| (801) 294-7558 |
| Full Name | Gregory D Hammond |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 26 Years |
| Location | 613 E Fort Union, Midvale, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942374020 | NPI | - | NPPES |
| 55967831202001 | Other | UT | BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 55967831205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jordan Valley Medical Center | West jordan, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Catholic Health Initiatives Colorado | 8022927342 | 998 |
| Silverton Group Llc | 5395884019 | 9 |
News Archive
In a pair of firsts, researchers at Case Western Reserve University and Massachusetts Institute of Technology have shown that the drug candidate phenanthriplatin can be more effective than an approved drug in vivo, and that a plant-virus-based carrier successfully delivers a drug in vivo.
Actavis plc, a leading global specialty pharmaceutical company committed to infectious disease treatment innovation, today announced the creation of SHARE ID (Sharing Hospital data to Advance Research and Enhance patient care in Infectious Diseases), a collaborative program to leverage real-world data to advance the delivery and effectiveness of care for patients with serious infections due to antibiotic-resistant pathogens.
The American Academy of Neurology is awarding the 2011 John Dystel Prize for Multiple Sclerosis Research to Brian G. Weinshenker, MD, of the Mayo Clinic in Rochester, Minnesota and a Fellow with the AAN.
A report issued Monday by the Obama administration found that the new health care law "will save Medicare $8 billion by the end of 2011, and $575 billion over the next decade, largely by improving care quality and preventing waste and fraud." The report also predicts that the overhaul will "extend the life of the program more than a decade.
Dietary restriction, or limited food intake without malnutrition, has beneficial effects on longevity in many species, including humans. A new study from the Sanford Burnham Prebys Medical Discovery Institute (SBP), published today in PLoS Genetics, represents a major advance in understanding how dietary restriction leads to these advantages.
› Verified 7 days ago
| Entity Name | Physician Group Of Utah Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477676930 PECOS PAC ID: 8022032234 Enrollment ID: O20060113000886 |
News Archive
In a pair of firsts, researchers at Case Western Reserve University and Massachusetts Institute of Technology have shown that the drug candidate phenanthriplatin can be more effective than an approved drug in vivo, and that a plant-virus-based carrier successfully delivers a drug in vivo.
Actavis plc, a leading global specialty pharmaceutical company committed to infectious disease treatment innovation, today announced the creation of SHARE ID (Sharing Hospital data to Advance Research and Enhance patient care in Infectious Diseases), a collaborative program to leverage real-world data to advance the delivery and effectiveness of care for patients with serious infections due to antibiotic-resistant pathogens.
The American Academy of Neurology is awarding the 2011 John Dystel Prize for Multiple Sclerosis Research to Brian G. Weinshenker, MD, of the Mayo Clinic in Rochester, Minnesota and a Fellow with the AAN.
A report issued Monday by the Obama administration found that the new health care law "will save Medicare $8 billion by the end of 2011, and $575 billion over the next decade, largely by improving care quality and preventing waste and fraud." The report also predicts that the overhaul will "extend the life of the program more than a decade.
Dietary restriction, or limited food intake without malnutrition, has beneficial effects on longevity in many species, including humans. A new study from the Sanford Burnham Prebys Medical Discovery Institute (SBP), published today in PLoS Genetics, represents a major advance in understanding how dietary restriction leads to these advantages.
› Verified 7 days ago
| Entity Name | Silverton Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629303169 PECOS PAC ID: 5395884019 Enrollment ID: O20091209000187 |
News Archive
In a pair of firsts, researchers at Case Western Reserve University and Massachusetts Institute of Technology have shown that the drug candidate phenanthriplatin can be more effective than an approved drug in vivo, and that a plant-virus-based carrier successfully delivers a drug in vivo.
Actavis plc, a leading global specialty pharmaceutical company committed to infectious disease treatment innovation, today announced the creation of SHARE ID (Sharing Hospital data to Advance Research and Enhance patient care in Infectious Diseases), a collaborative program to leverage real-world data to advance the delivery and effectiveness of care for patients with serious infections due to antibiotic-resistant pathogens.
The American Academy of Neurology is awarding the 2011 John Dystel Prize for Multiple Sclerosis Research to Brian G. Weinshenker, MD, of the Mayo Clinic in Rochester, Minnesota and a Fellow with the AAN.
A report issued Monday by the Obama administration found that the new health care law "will save Medicare $8 billion by the end of 2011, and $575 billion over the next decade, largely by improving care quality and preventing waste and fraud." The report also predicts that the overhaul will "extend the life of the program more than a decade.
Dietary restriction, or limited food intake without malnutrition, has beneficial effects on longevity in many species, including humans. A new study from the Sanford Burnham Prebys Medical Discovery Institute (SBP), published today in PLoS Genetics, represents a major advance in understanding how dietary restriction leads to these advantages.
› Verified 7 days ago
| Entity Name | Utah Regional Hospitalists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962821223 PECOS PAC ID: 4789807165 Enrollment ID: O20140604000236 |
News Archive
In a pair of firsts, researchers at Case Western Reserve University and Massachusetts Institute of Technology have shown that the drug candidate phenanthriplatin can be more effective than an approved drug in vivo, and that a plant-virus-based carrier successfully delivers a drug in vivo.
Actavis plc, a leading global specialty pharmaceutical company committed to infectious disease treatment innovation, today announced the creation of SHARE ID (Sharing Hospital data to Advance Research and Enhance patient care in Infectious Diseases), a collaborative program to leverage real-world data to advance the delivery and effectiveness of care for patients with serious infections due to antibiotic-resistant pathogens.
The American Academy of Neurology is awarding the 2011 John Dystel Prize for Multiple Sclerosis Research to Brian G. Weinshenker, MD, of the Mayo Clinic in Rochester, Minnesota and a Fellow with the AAN.
A report issued Monday by the Obama administration found that the new health care law "will save Medicare $8 billion by the end of 2011, and $575 billion over the next decade, largely by improving care quality and preventing waste and fraud." The report also predicts that the overhaul will "extend the life of the program more than a decade.
Dietary restriction, or limited food intake without malnutrition, has beneficial effects on longevity in many species, including humans. A new study from the Sanford Burnham Prebys Medical Discovery Institute (SBP), published today in PLoS Genetics, represents a major advance in understanding how dietary restriction leads to these advantages.
› Verified 7 days ago
| Entity Name | Catholic Health Initiatives Colorado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942903562 PECOS PAC ID: 8022927342 Enrollment ID: O20230615001995 |
News Archive
In a pair of firsts, researchers at Case Western Reserve University and Massachusetts Institute of Technology have shown that the drug candidate phenanthriplatin can be more effective than an approved drug in vivo, and that a plant-virus-based carrier successfully delivers a drug in vivo.
Actavis plc, a leading global specialty pharmaceutical company committed to infectious disease treatment innovation, today announced the creation of SHARE ID (Sharing Hospital data to Advance Research and Enhance patient care in Infectious Diseases), a collaborative program to leverage real-world data to advance the delivery and effectiveness of care for patients with serious infections due to antibiotic-resistant pathogens.
The American Academy of Neurology is awarding the 2011 John Dystel Prize for Multiple Sclerosis Research to Brian G. Weinshenker, MD, of the Mayo Clinic in Rochester, Minnesota and a Fellow with the AAN.
A report issued Monday by the Obama administration found that the new health care law "will save Medicare $8 billion by the end of 2011, and $575 billion over the next decade, largely by improving care quality and preventing waste and fraud." The report also predicts that the overhaul will "extend the life of the program more than a decade.
Dietary restriction, or limited food intake without malnutrition, has beneficial effects on longevity in many species, including humans. A new study from the Sanford Burnham Prebys Medical Discovery Institute (SBP), published today in PLoS Genetics, represents a major advance in understanding how dietary restriction leads to these advantages.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory D Hammond, MD 1580 W Antelope Dr Ste 280, Layton, UT 84041-1222 Ph: (801) 773-0925 | Gregory D Hammond, MD 613 E Fort Union, Suite #a102, Midvale, UT 84047-5531 Ph: (801) 294-9333 |
News Archive
In a pair of firsts, researchers at Case Western Reserve University and Massachusetts Institute of Technology have shown that the drug candidate phenanthriplatin can be more effective than an approved drug in vivo, and that a plant-virus-based carrier successfully delivers a drug in vivo.
Actavis plc, a leading global specialty pharmaceutical company committed to infectious disease treatment innovation, today announced the creation of SHARE ID (Sharing Hospital data to Advance Research and Enhance patient care in Infectious Diseases), a collaborative program to leverage real-world data to advance the delivery and effectiveness of care for patients with serious infections due to antibiotic-resistant pathogens.
The American Academy of Neurology is awarding the 2011 John Dystel Prize for Multiple Sclerosis Research to Brian G. Weinshenker, MD, of the Mayo Clinic in Rochester, Minnesota and a Fellow with the AAN.
A report issued Monday by the Obama administration found that the new health care law "will save Medicare $8 billion by the end of 2011, and $575 billion over the next decade, largely by improving care quality and preventing waste and fraud." The report also predicts that the overhaul will "extend the life of the program more than a decade.
Dietary restriction, or limited food intake without malnutrition, has beneficial effects on longevity in many species, including humans. A new study from the Sanford Burnham Prebys Medical Discovery Institute (SBP), published today in PLoS Genetics, represents a major advance in understanding how dietary restriction leads to these advantages.
› Verified 7 days ago
Dr. Philip Nathanael Isenberg, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 7495 S State St, Midvale, UT 84047 Phone: 801-213-9400 Fax: 801-213-9458 | |
Dr. Susan Ann Terry, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 7495 S State St, Midvale, UT 84047 Phone: 801-213-9400 | |
Mehrnoosh Shakeri, MD, MPH Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 7495 S State St, Midvale, UT 84047 Phone: 801-213-9400 | |
Anthony R. Wallin, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1225 Fort Union Blvd, Suite 200, Midvale, UT 84047 Phone: 801-233-4400 Fax: 801-233-4410 |